Faculdade de Medicina, Heart Institute (InCor), Hospital das Cínicas, Universidade de São Paulo, São Paulo, SP, Brazil.
Clinics (Sao Paulo). 2013 Jul;68(7):992-6. doi: 10.6061/clinics/2013(07)17.
Obstructive sleep apnea is common among patients with hypertrophic cardiomyopathy and may contribute to poor cardiovascular outcomes. However, obstructive sleep apnea is largely unrecognized in this population. We sought to identify the clinical predictors of obstructive sleep apnea among patients with hypertrophic cardiomyopathy.
Consecutive patients with hypertrophic cardiomyopathy were recruited from a tertiary University Hospital and were evaluated using validated sleep questionnaires (Berlin and Epworth) and overnight portable monitoring. Ninety patients (males, 51%; age, 46±15 years; body mass index, 26.6±4.9 kg/m2) were included, and obstructive sleep apnea (respiratory disturbance index ≥15 events/h) was present in 37 patients (41%).
Compared with the patients without obstructive sleep apnea, patients with obstructive sleep apnea were older and had higher body mass index, larger waist circumference, larger neck circumference, and higher prevalence of atrial fibrillation. Excessive daytime sleepiness (Epworth scale) was low and similar in the patients with and without obstructive sleep apnea, respectively. The only predictors of obstructive sleep apnea (using a logistic regression analysis) were age ≥45 years (odds ratio [OR], 4.46; 95% confidence interval [CI 95%], 1.47-13.54; p = 0.008) and the presence of atrial fibrillation [OR, 5.37; CI 95%, 1.43-20.12; p = 0.013].
Consistent clinical predictors of obstructive sleep apnea are lacking for patients with hypertrophic cardiomyopathy, which suggests that objective sleep evaluations should be considered in this population, particularly among elderly patients with atrial fibrillation.
肥厚型心肌病患者中阻塞性睡眠呼吸暂停较为常见,并且可能导致心血管不良结局。然而,该人群中阻塞性睡眠呼吸暂停的识别率较低。我们旨在确定肥厚型心肌病患者中阻塞性睡眠呼吸暂停的临床预测因素。
连续入选于某三级大学医院就诊的肥厚型心肌病患者,采用经过验证的睡眠问卷(柏林问卷和 Epworth 嗜睡量表)和夜间便携式监测进行评估。共入选 90 例患者(男性占 51%;年龄 46±15 岁;体重指数 26.6±4.9kg/m2),其中 37 例(41%)存在阻塞性睡眠呼吸暂停(呼吸暂停低通气指数≥15 次/小时)。
与不存在阻塞性睡眠呼吸暂停的患者相比,存在阻塞性睡眠呼吸暂停的患者年龄更大,体重指数更高,腰围、颈围更大,心房颤动发生率更高。日间嗜睡(Epworth 嗜睡量表)评分较低,且在存在或不存在阻塞性睡眠呼吸暂停的患者中无差异。阻塞性睡眠呼吸暂停的唯一预测因素(采用 logistic 回归分析)为年龄≥45 岁(比值比[OR],4.46;95%置信区间[CI 95%],1.47-13.54;p=0.008)和心房颤动的存在(OR,5.37;CI 95%,1.43-20.12;p=0.013)。
肥厚型心肌病患者中缺乏阻塞性睡眠呼吸暂停的一致临床预测因素,这提示该人群,特别是存在心房颤动的老年患者,应考虑进行客观睡眠评估。